GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inner Mongolia Furui Medical Science Co Ltd (SZSE:300049) » Definitions » Long-Term Capital Lease Obligation

Inner Mongolia Furui Medical Science Co (SZSE:300049) Long-Term Capital Lease Obligation : ¥50 Mil (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Inner Mongolia Furui Medical Science Co Long-Term Capital Lease Obligation?

Inner Mongolia Furui Medical Science Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥50 Mil.

Inner Mongolia Furui Medical Science Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2024 (¥49 Mil) to Dec. 2024 (¥55 Mil) but then declined from Dec. 2024 (¥55 Mil) to Mar. 2025 (¥50 Mil).

Inner Mongolia Furui Medical Science Co's annual Long-Term Capital Lease Obligation increased from Dec. 2022 (¥42 Mil) to Dec. 2023 (¥45 Mil) and increased from Dec. 2023 (¥45 Mil) to Dec. 2024 (¥55 Mil).


Inner Mongolia Furui Medical Science Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Inner Mongolia Furui Medical Science Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inner Mongolia Furui Medical Science Co Long-Term Capital Lease Obligation Chart

Inner Mongolia Furui Medical Science Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.11 54.13 41.83 44.90 55.24

Inner Mongolia Furui Medical Science Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.04 52.49 49.24 55.24 50.44

Inner Mongolia Furui Medical Science Co  (SZSE:300049) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Inner Mongolia Furui Medical Science Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Inner Mongolia Furui Medical Science Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Inner Mongolia Furui Medical Science Co Business Description

Traded in Other Exchanges
N/A
Address
No. 103 Jiefang Road, Wulanchabu League, Inner Mongolia Autonomous Region, Jining, CHN, 012000
Inner Mongolia Furui Medical Science Co Ltd is a China based medical service platform company. It provides disease diagnosis, drug treatment and chronic disease management centered on the liver disease field. The product portfolio of the company includes tablets, capsules, and plaster. In addition, the company is also engaged in providing health-care services.
Executives
Di Xiu Juan Executives
Lin Xin Directors, Directors, and Executives
Wang Guan Yi Director
Wang Li Qun Supervisors
Wang Xin Hong Executives
Shuo Fei Directors, executives
Zhang Sui Yong Director
Zhao Xiao Dong Independent director
Yang Jin Bin Supervisors

Inner Mongolia Furui Medical Science Co Headlines

No Headlines